Research Areas
Links
Biography and Research Information
OverviewAI-generated summary
K. Agoramurthi's research focuses on respiratory health, particularly in individuals with cystic fibrosis. Recent publications investigate methods for delivering albuterol through laryngeal mask airways and explore the impact of disinfection on nebulizer performance. Studies have examined the reduction of acid suppressor therapy in children with cystic fibrosis as a quality improvement initiative. Additionally, Agoramurthi has published on necrotizing pneumonia in young adults diagnosed with cystic fibrosis. Collaborations include work with Ariel Berlinski and Zena Ghazala at the University of Arkansas for Medical Sciences, with whom Agoramurthi has co-authored multiple publications.
Metrics
- h-index: 1
- Publications: 6
- Citations: 1
Selected Publications
-
Necrotizing Pneumonia in a Young Adult With Cystic Fibrosis (2024)
-
Effect of Disinfection Method and Testing Methodology on the Performance of a Breath-Enhanced Jet Nebulizer (2023)
-
455 Performance of a breath-enhanced nebulizer after repeated cycles of thermal or chemical disinfection (2023)
Collaboration Network
Top Collaborators
- Necrotizing Pneumonia in a Young Adult With Cystic Fibrosis
- Effect of Disinfection With Baby-bottle Sterilizer of Reusable Breath-enhanced Nebulizers on Aerosolized Albuterol Output and Characteristics
- 455 Performance of a breath-enhanced nebulizer after repeated cycles of thermal or chemical disinfection
- Effect of Disinfection Method and Testing Methodology on the Performance of a Breath-Enhanced Jet Nebulizer
- Albuterol Delivery Through Laryngeal Mask Airways
Showing 5 of 6 shared publications
- Necrotizing Pneumonia in a Young Adult With Cystic Fibrosis
- 740 Reduction of acid suppressor therapy in children with cystic fibrosis: a quality improvement initiative
- 740 Reduction of acid suppressor therapy in children with cystic fibrosis: a quality improvement initiative
- 740 Reduction of acid suppressor therapy in children with cystic fibrosis: a quality improvement initiative
- 740 Reduction of acid suppressor therapy in children with cystic fibrosis: a quality improvement initiative
- 740 Reduction of acid suppressor therapy in children with cystic fibrosis: a quality improvement initiative
- 740 Reduction of acid suppressor therapy in children with cystic fibrosis: a quality improvement initiative
- 740 Reduction of acid suppressor therapy in children with cystic fibrosis: a quality improvement initiative
- 740 Reduction of acid suppressor therapy in children with cystic fibrosis: a quality improvement initiative
- 740 Reduction of acid suppressor therapy in children with cystic fibrosis: a quality improvement initiative
- 740 Reduction of acid suppressor therapy in children with cystic fibrosis: a quality improvement initiative
Similar Researchers
Based on overlapping research topics